1. Home
  2. ELTX vs ZVIA Comparison

ELTX vs ZVIA Comparison

Compare ELTX & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ZVIA
  • Stock Information
  • Founded
  • ELTX 2011
  • ZVIA 2007
  • Country
  • ELTX United States
  • ZVIA United States
  • Employees
  • ELTX N/A
  • ZVIA N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • ELTX Health Care
  • ZVIA Consumer Staples
  • Exchange
  • ELTX Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • ELTX 121.7M
  • ZVIA 142.5M
  • IPO Year
  • ELTX N/A
  • ZVIA 2021
  • Fundamental
  • Price
  • ELTX $5.40
  • ZVIA $2.66
  • Analyst Decision
  • ELTX Strong Buy
  • ZVIA Hold
  • Analyst Count
  • ELTX 2
  • ZVIA 3
  • Target Price
  • ELTX $9.50
  • ZVIA $2.58
  • AVG Volume (30 Days)
  • ELTX 35.2K
  • ZVIA 603.9K
  • Earning Date
  • ELTX 05-19-2025
  • ZVIA 05-07-2025
  • Dividend Yield
  • ELTX N/A
  • ZVIA N/A
  • EPS Growth
  • ELTX N/A
  • ZVIA N/A
  • EPS
  • ELTX N/A
  • ZVIA N/A
  • Revenue
  • ELTX N/A
  • ZVIA $154,273,000.00
  • Revenue This Year
  • ELTX N/A
  • ZVIA $5.70
  • Revenue Next Year
  • ELTX N/A
  • ZVIA $7.10
  • P/E Ratio
  • ELTX N/A
  • ZVIA N/A
  • Revenue Growth
  • ELTX N/A
  • ZVIA N/A
  • 52 Week Low
  • ELTX $3.34
  • ZVIA $0.62
  • 52 Week High
  • ELTX $11.45
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 48.43
  • ZVIA 57.74
  • Support Level
  • ELTX $4.85
  • ZVIA $1.97
  • Resistance Level
  • ELTX $5.94
  • ZVIA $3.20
  • Average True Range (ATR)
  • ELTX 0.50
  • ZVIA 0.22
  • MACD
  • ELTX 0.14
  • ZVIA 0.05
  • Stochastic Oscillator
  • ELTX 56.45
  • ZVIA 55.69

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: